Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer’s Disease and Parkinson’s Disease
Hui‐Zhi Long, Yan Cheng, Ziwei Zhou, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 293

Showing 1-25 of 293 citing articles:

Apoptosis in Alzheimer’s disease: insight into the signaling pathways and therapeutic avenues
Sneha Kumari, Rishika Dhapola, Dibbanti HariKrishnaReddy
APOPTOSIS (2023) Vol. 28, Iss. 7-8, pp. 943-957
Closed Access | Times Cited: 113
Neuroprotective Activities of Curcumin in Parkinson’s Disease: A Review of the Literature
Eslam El Nebrisi
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11248-11248
Open Access | Times Cited: 110
Inflammatory Processes in Alzheimer’s Disease—Pathomechanism, Diagnosis and Treatment: A Review
Bartosz Twarowski, Mariola Herbet
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6518-6518
Open Access | Times Cited: 85
Advances in the study of macrophage polarization in inflammatory immune skin diseases
Tingting Xia, Sheng-Ping Fu, Ruilin Yang, et al.
Journal of Inflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 42
PI3K/AKT signaling pathway: Molecular mechanisms and therapeutic potential in depression
Ningning Guo, Xin Wang, Muran Xu, et al.
Pharmacological Research (2024) Vol. 206, pp. 107300-107300
Open Access | Times Cited: 16
Examining the wound healing potential of curcumin-infused electrospun nanofibers from polyglutamic acid and gum arabic
Cuilin Cheng, Rongchun Wang, Jiapei Ma, et al.
International Journal of Biological Macromolecules (2024) Vol. 267, pp. 131237-131237
Closed Access | Times Cited: 14
Type 2 Diabetes Mellitus Exacerbates Pathological Processes of Parkinson's Disease: Insights from Signaling Pathways Mediated by Insulin Receptors
Shufen Liu, Tingting Liu, Jingwen Li, et al.
Neuroscience Bulletin (2025)
Closed Access | Times Cited: 1
Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: a groundbreaking cell-free approach
Hadi Yari, M. V. Mikhailova, Mahsa Mardasi, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 59
Neuroprotective Effects of Cholinesterase Inhibitors: Current Scenario in Therapies for Alzheimer’s Disease and Future Perspectives
Natália Moreira, Jéssica Ellen Barbosa de Freitas Lima, Marcelo Fiori Marchiori, et al.
Journal of Alzheimer s Disease Reports (2022) Vol. 6, Iss. 1, pp. 177-193
Open Access | Times Cited: 54
The PI3K-AKT pathway: A plausible therapeutic target in Parkinson's disease
Ahsas Goyal, Anant Agrawal, Aanchal Verma, et al.
Experimental and Molecular Pathology (2022) Vol. 129, pp. 104846-104846
Open Access | Times Cited: 53
Molecular Mechanisms and Therapeutic Potential of α- and β-Asarone in the Treatment of Neurological Disorders
Rengasamy Balakrishnan, Duk-Yeon Cho, In‐Su Kim, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 281-281
Open Access | Times Cited: 38
The Molecular Mechanisms of the Relationship between Insulin Resistance and Parkinson’s Disease Pathogenesis
Viviana A. Ruiz‐Pozo, Rafael Tamayo‐Trujillo, Santiago Cadena-Ullauri, et al.
Nutrients (2023) Vol. 15, Iss. 16, pp. 3585-3585
Open Access | Times Cited: 26
The Exosome-Mediated PI3K/Akt/mTOR Signaling Pathway in Neurological Diseases
Amin Iranpanah, Leila Kooshki, Seyed Zachariah Moradi, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 1006-1006
Open Access | Times Cited: 24
Neuromodulatory effect of vardenafil on aluminium chloride/d-galactose induced Alzheimer’s disease in rats: emphasis on amyloid-beta, p-tau, PI3K/Akt/p53 pathway, endoplasmic reticulum stress, and cellular senescence
Heba H. Awad, Mahmoud A. Desouky, Alaa Zidan, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 5, pp. 2653-2673
Open Access | Times Cited: 23
Caffeic Acid, a Polyphenolic Micronutrient Rescues Mice Brains against Aβ-Induced Neurodegeneration and Memory Impairment
Amjad Khan, Jun Sung Park, Min Hwa Kang, et al.
Antioxidants (2023) Vol. 12, Iss. 6, pp. 1284-1284
Open Access | Times Cited: 22
PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson’s disease in rats
Heba A. Farid, Rabab H. Sayed, Marwa El-Sayed El-Shamarka, et al.
Inflammopharmacology (2023) Vol. 32, Iss. 2, pp. 1421-1437
Open Access | Times Cited: 22
Neuroprotective effect of a medium-chain triglyceride ketogenic diet on MPTP-induced Parkinson’s disease mice: a combination of transcriptomics and metabolomics in the substantia nigra and fecal microbiome
Wenlong Zhang, Shiyu Chen, Xingting Huang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 21
The Molecular Pathway of p75 Neurotrophin Receptor (p75NTR) in Parkinson’s Disease: The Way of New Inroads
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 5, pp. 2469-2480
Closed Access | Times Cited: 21
Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential
Josh Allen, Shannon Dames, Claire J. Foldi, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 3, pp. 671-685
Closed Access | Times Cited: 12
Crosstalk between MiRNAs/lncRNAs and PI3K/AKT signaling pathway in diabetes mellitus: Mechanistic and therapeutic perspectives
Seyed Mohsen Aghaei Zarch
Non-coding RNA Research (2024) Vol. 9, Iss. 2, pp. 486-507
Open Access | Times Cited: 10
An insight into role of amino acids as antioxidants via NRF2 activation
Melford C. Egbujor, Olugbemi T. Olaniyan, Chigbundu N. Emeruwa, et al.
Amino Acids (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 9
Neuroprotective potential of Erigeron bonariensis ethanolic extract against ovariectomized/D-galactose-induced memory impairments in female rats in relation to its metabolite fingerprint as revealed using UPLC/MS
Weam W. Ibrahim, Rabab H. Sayed, Mohamed F. Abdelhameed, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 2, pp. 1091-1112
Open Access | Times Cited: 7
Protective effects and mechanism of puerarin targeting PI3K/Akt signal pathway on neurological diseases
Qian Wang, Zinuo Shen, Shujing Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33
Kunxian Capsule Extract Inhibits Angiogenesis in Zebrafish Embryos via PI3K/AKT-MAPK-VEGF Pathway
Rui-jiao Ma, Kannan Maharajan, Qing Xia, et al.
Chinese Journal of Integrative Medicine (2022) Vol. 29, Iss. 2, pp. 137-145
Closed Access | Times Cited: 28
FALCON systematically interrogates free fatty acid biology and identifies a novel mediator of lipotoxicity
Nicolas Wieder, Juliana Coraor, Choah Kim, et al.
Cell Metabolism (2023) Vol. 35, Iss. 5, pp. 887-905.e11
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top